Our Company

Clive Bertram

Chief Commercial Officer

Clive Bertram joins ObsEva with nearly 30 years of experience in commercialization, strategic, corporate and business development. in the pharmaceutical industry. Most recently, he served as CCO at Petra Pharma and Sangart. Clive Bertram also served as an independent consultant leading client thinking for strategic and marketing planning insight as well as launch excellence and implementation. Prior to his CCO roles, Clive Bertram held senior management positions at Pharmion Limited, Chiron Biopharmaceuticals, Celltech and Eli Lilly.

He holds a BSc (Hons.) in Pharmacology and Chemistry from the University of Sheffield

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue